NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-020-2018-0-US-04 CYTOMEGALOVIRUS-BASED VACCINE EXPRESSING EBOLA VIRUS GLYCOPROTEIN US National Stage 15/547,365 Abandoned
NCI E-193-2017-0-US-01 Ultrasound Sensitive Peptide Nanoparticles For Spatially Resolved Molecule Delivery US 62/538,116 Abandoned
NIAID E-300-2009-5-US-11 NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE US DIV 15/661,867 10035845 Issued PDF
NIDDK E-121-2019-2-US-01 ADENOSINE KINASE ISOFORM-SPECIFIC CANCER TREATMENT US 62/537,879 Abandoned
NIAID E-060-2015-0-KR-12 Novel Multivalent Nanoparticle-Based Vaccines KR National Stage 10-2017-7021112 Pending
NCI E-040-2012-0-AU-25 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen AU DIV 2017208279 Issued
NCATS E-046-2018-1-US-01 COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING NEURODEGENERATIVE DISEASES VIA AUTOPHAGY INDUCTION US 62/537,260 Abandoned
NHLBI E-121-2016-1-SG-05 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE SG National Stage 11201810871W Issued
NHLBI E-121-2016-1-HK-07 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE HK EP 19130894.9 Issued
NHLBI E-121-2016-1-IE-13 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE IE EP 17754517.5 Issued
NHLBI E-121-2016-1-DE-09 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE DE EP 17754517.5 Issued
NHLBI E-121-2016-1-FR-10 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE FR EP 17754517.5 Issued
NHLBI E-121-2016-1-GB-11 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE GB EP 17754517.5 Issued
NHLBI E-121-2016-1-CH-08 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE CH EP 17754517.5 Issued
NHLBI E-121-2016-1-EP-03 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE EP National Stage 17754517.5 Issued
NIBIB E-232-2014-0-US-04 Resolution Enhancement for Light Sheet Microscopy Systems and Methods US National Stage 15/511,580 10401604 Issued PDF
NHLBI E-121-2016-1-PCT-01 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE PCT PCT COMB PCT/US2017/043774 Expired
NCI E-115-2016-0-PCT-02 Methods of Making 18F-Labeled Precursors and Peptides, Labeled C-MET Binding Peptides, and Methods of Use Thereof PCT PCT PCT/US2017/043694 Expired
NIAID E-020-2018-0-EP-06 CYTOMEGALOVIRUS-BASED VACCINE EXPRESSING EBOLA VIRUS GLYCOPROTEIN EP National Stage 16701948.8 Abandoned
NCI E-276-2014-0-US-03 METHODS AND KITS FOR MEASURING AND QUANTIFYING DNA DOUBLE-STRANDED BREAKS USING GAMMA-H2AX AND H2AX US National Stage 15/545,402 10809268 Issued PDF
NCI E-292-2014-0-US-04 HYDROGELS AND USE THEREOF IN ANASTOMOSIS PROCEDURES US National Stage 15/545,647 10086108 Issued PDF
NINDS E-101-2012-1-US-21 Deuterated 3,4-Dihydroxyphenylserine (Deuterated L-DOPS) US CON 15/656,035 Abandoned
NIDCR E-198-2017-0-US-01 PREVENTION AND THERAPY OF DIABETES, OBESITY, ASTHMA AND AUTOIMMUNE DISEASES US 62/535,767 Abandoned
NCI E-211-2016-0-PCT-02 MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 (GPC2) AND USE THEREOF PCT PCT PCT/US2017/043112 Expired
NCI E-211-2016-0-EP-06 MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 (GPC2) AND USE THEREOF EP National Stage 17746316.3 Issued
NCI E-211-2016-0-CA-04 MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 (GPC2) AND USE THEREOF CA National Stage 3031559 Issued
NCI E-211-2016-0-AU-03 MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 (GPC2) AND USE THEREOF AU National Stage 2017305170 Abandoned
NIAMS E-192-2017-0-US-01 Antibodies to Hepatitis B E-Antigen And Diagnostic and Therapeutic Uses Thereof US 62/534,603 Abandoned
NCI E-162-2017-0-US-01 Combination Therapy For Chordoma US 62/534,161 Abandoned
NCATS E-282-2014-0-US-03 INHIBITORS OF PHOSPHOGLYCERATE DEHYDROGENASE (PHGDH) AND USES THEREOF US National Stage 15/543,643 11225469 Issued PDF
NCATS E-026-2016-0-US-10 Compounds for Improving mRNA Splicing US National Stage 15/543,826 10676475 Issued PDF
NIAID E-120-2001-0-US-90 DEVELOPMENT OF MUTATIONS USEFUL FOR ATTENUATING DENGUE VIRUSES AND CHIMERIC DENGUE VIRUSES US DIV 15/650,482 10500264 Expired PDF
NCATS E-202-2016-4-PCT-01 Repurposing CDK Inhibitors For Treatment Of Zika Virus Infection PCT PCT COMB PCT/US2017/042231 Expired
NCATS E-202-2016-4-US-02 Compounds and Methods for Treatment and Prevention of Flavivirus Infection US ORD 15/650,568 Abandoned
NCATS E-202-2016-4-BR-03 Repurposing CDK Inhibitors For Treatment Of Zika Virus Infection BR National Stage BR112019000796-2 Pending
NIAID E-145-2004-3-US-06 Monoclonal Antibodies Against Orthopoxviruses US DIV 15/650,103 Abandoned
NCI E-282-2016-2-US-05 Methods For Pre-conditioning Patients For Cell Therapy US CON 15/649,369 10322146 Issued PDF
NCI E-126-2016-0-PCT-02 IL-15/IL-15 RECEPTOR ALPHA TREATMENT REGIMENS AND USE WITH THERAPEUTIC VACCINES PCT PCT PCT/US2017/042002 Expired
NCI E-275-2014-0-US-06 FUROQUINOLINEDIONES AS INHIBITORS OF TDP2 US National Stage 15/542,560 10906914 Issued PDF
NCATS E-203-2012-0-US-08 METHODS AND COMPOSITIONS FOR THE INHIBITION OF PIN1 US CON 15/645,683 10413548 Issued PDF
NIA E-151-2017-0-US-01 FATTY ACID DERIVATIVES AND THEIR USE US 62/529,846 Abandoned
NCI E-278-2014-0-US-03 USE OF PEPTIDE-BASED INHIBITORS OF THE STAT3-IL 10 PATHWAY FOR TREATING BACTERIAL INFECTION AND GRANULOMATOUS DISEASE US National Stage 15/541,871 10512673 Issued PDF
NCI E-140-2017-0-US-01 COMPOUNDS FOR TREATING CANCER US 62/529,063 Abandoned
NCI E-265-2011-0-JP-13 Anti-CD22 Chimeric Antigen Receptors JP DIV 132749/2017 Abandoned
NCI E-053-2015-1-US-02 MYC G-QUADRUPLEX STABILIZING SMALL MOLECULES AND THEIR USE US National Stage 15/541,676 10196372 Issued PDF
NINDS E-252-2016-1-PCT-01 Diagnosing COL6-Related Disorders And Methods For Treating Same PCT PCT COMB PCT/US2017/040726 Expired
NIDCR E-170-2017-0-US-01 USE OF FIBULIN-7 AND C-TERMINAL FRAGMENTS THEREOF TO TREAT SEPSIS US 62/528,358 Abandoned
NHLBI E-120-2016-1-HK-04 HERV-E REACTIVE T CELL RECEPTORS AND METHODS OF USE HK National Stage 19126505.7 Issued
NHLBI E-120-2016-1-IE-16 HERV-E REACTIVE T CELL RECEPTORS AND METHODS OF USE IE EP 17742333.2 Issued
NHLBI E-120-2016-1-NL-17 HERV-E REACTIVE T CELL RECEPTORS AND METHODS OF USE NL EP 17742333.2 Issued